Multi-omics network analyses
to identify key drivers of disease initiation and progression in the
preclinical phase of
inflammatory bowel disease
(IBD).
Funding: Support for this tool has been provided by the Kenneth Rainin Foundation (Grant
#20210021)
Details related with this interface:
1. Torres, J., Petralia, F., Sato, T., Wang, P., Telesco, S.E., Strauss, R., Li, X.J., Laird, R.M., Gutierrez,
R.L., Porter, C.K. and Plevy, S., 2020. Serum biomarkers identify patients who will develop
inflammatory bowel diseases up to 5 years before diagnosis. Gastroenterology, 159(1), pp.96-104.
2. Porter CK, Riddle MS, Gutierrez RL, et al. Cohort profile of the PRoteomic Evaluation and
Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization,
design, and baseline characteristics. Contemporary Clinical Trials Communications 2019; 14: 100345.
ASSOCIATION ANALYSIS
NETWORK ANALYSIS
This work is licensed under
CC-BY-NC-SA-4.0
This work is licensed under